Alpha Tau Medical reported net income of $45.81M for the quarter ended Jun 2026. This income statement covers 23 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||
| Cost of RevenueCost of Rev | 0.10M | 0.13M | 0.21M | 0.12M | 0.25M | 0.40M | 0.40M | 0.52M | 0.55M | 0.45M | 0.53M | 0.60M | 0.53M | 0.69M | 0.46M | 0.46M | 0.49M | 0.45M | 0.24M | 0.31M | |||
| Operating items | |||||||||||||||||||||||
| Research & DevelopmentR&D | 3.03M | 3.23M | 5.24M | 5.45M | 4.83M | 5.38M | 6.31M | 5.96M | 6.67M | 7.49M | 6.45M | 6.87M | 6.17M | 7.53M | 7.17M | 7.01M | 8.31M | 9.58M | 10.97M | 9.91M | |||
| Selling, General & AdministrativeSG&A | 0.50M | 0.59M | 3.34M | 2.44M | 2.28M | 2.21M | 1.94M | 1.69M | 1.70M | 2.00M | 1.44M | 1.59M | 1.59M | 2.05M | 1.68M | 2.18M | 1.93M | 2.57M | 2.10M | 3.56M | |||
| Operating ExpensesOpex | 3.53M | 3.82M | 8.57M | 7.89M | 7.11M | 7.59M | 8.24M | 7.65M | 8.37M | 9.49M | 7.89M | 8.45M | 7.76M | 9.59M | 8.85M | 9.19M | 10.24M | 12.15M | 13.07M | 13.47M | |||
| Operating IncomeOp. Inc | 3.63M | 3.94M | 8.78M | 8.01M | 7.36M | 7.99M | 8.64M | 8.17M | 8.93M | 9.94M | 8.42M | 9.05M | 8.29M | 10.27M | 9.31M | 9.65M | 10.73M | 12.60M | 13.31M | 13.78M | |||
| EBIT | 3.63M | 3.94M | 8.78M | 8.01M | 7.36M | 7.99M | 8.64M | 8.17M | 8.93M | 9.94M | 8.42M | 9.05M | 8.29M | 10.27M | 9.31M | 9.65M | 10.73M | 12.60M | 13.31M | 13.78M | |||
| Non-operating items | |||||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 16.96M | -6.02M | -6.11M | 10.82M | -6.25M | 8.14M | |||||||||||||||||
| Non Operating IncomeNon Op. Inc. | 1.17M | -13.59M | 16.96M | -6.02M | -4.74M | -7.52M | -0.48M | 0.99M | -4.46M | 5.69M | -0.44M | -1.69M | -1.37M | 3.54M | -0.72M | 0.40M | 0.96M | -0.89M | 9.64M | 31.80M | |||
| Net income details | |||||||||||||||||||||||
| EBT | 4.80M | 3.79M | 25.74M | 1.99M | 2.61M | 3.39M | 8.17M | 8.67M | 4.95M | 7.36M | 7.98M | 7.37M | 6.92M | 9.47M | 8.59M | 10.05M | 11.69M | 12.17M | 22.95M | 45.58M | |||
| Tax ProvisionsTaxes | -0.01M | -0.01M | 0.00M | 0.01M | 0.01M | 0.00M | 0.02M | 0.03M | -0.04M | 0.01M | 0.00M | 0.00M | 0.00M | 0.10M | 0.07M | -0.01M | -0.04M | -0.01M | 0.23M | ||||
| Profit After TaxPAT | 4.80M | 3.78M | 25.74M | 2.00M | 2.62M | 3.40M | 8.19M | 8.69M | 4.91M | 7.37M | 7.98M | 7.37M | 6.92M | 9.48M | 8.69M | 10.11M | 11.69M | 12.14M | 22.94M | 45.81M | |||
| Income from Continuing OperationsIncome (Continuing) | 4.81M | 3.81M | 25.74M | 1.99M | 2.60M | 3.39M | 8.14M | 8.64M | 4.99M | 7.35M | 7.98M | 7.36M | 6.92M | 9.47M | 8.49M | 9.98M | 11.70M | 12.21M | 22.96M | 45.35M | |||
| Consolidated Net IncomeConsol Net Inc. | 4.81M | 3.81M | 25.74M | 1.99M | 2.60M | 3.39M | 8.14M | 8.64M | 4.99M | 7.35M | 7.98M | 7.36M | 6.92M | 9.47M | 8.49M | 9.98M | 11.70M | 12.21M | 22.96M | 45.35M | |||
| Income towards Parent CompanyParent Net Inc | 4.81M | 3.81M | 25.74M | 1.99M | 2.60M | 3.39M | 8.14M | 8.64M | 4.99M | 7.35M | 7.98M | 7.36M | 6.92M | 9.47M | 8.49M | 9.98M | 11.70M | 12.21M | 22.96M | 45.35M | |||
| Net Income towards Common StockholdersNet Income | 4.81M | 3.81M | 25.74M | 1.99M | 2.60M | 3.39M | 8.14M | 8.64M | 4.99M | 7.35M | 7.98M | 7.36M | 6.92M | 9.47M | 8.49M | 9.98M | 11.70M | 12.21M | 22.96M | 45.35M | |||
| Additional items | |||||||||||||||||||||||
| EPS (Basic) | 0.12 | 0.09 | 0.64 | 0.05 | 0.06 | 0.05 | 0.13 | 0.14 | 0.08 | 0.11 | 0.12 | 0.11 | 0.10 | 0.14 | 0.12 | 0.14 | 0.17 | 0.15 | 0.28 | 0.56 | |||
| EPS (Diluted) | 0.12 | 0.09 | 0.64 | 0.05 | 0.06 | 0.05 | 0.13 | 0.14 | 0.08 | 0.11 | 0.12 | 0.11 | 0.10 | 0.14 | 0.12 | 0.14 | 0.17 | 0.15 | 0.28 | 0.56 | |||
| Shares Outstanding | 40.27M | 40.53M | 40.53M | 40.53M | 40.53M | 63.53M | 63.53M | 63.53M | 63.53M | 69.38M | 69.38M | 69.38M | 69.38M | 69.93M | 69.93M | 69.93M | 69.93M | 80.58M | 80.58M | 80.58M | |||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 40.27M | 40.53M | 40.53M | 40.53M | 40.53M | 63.53M | 63.53M | 63.53M | 63.53M | 69.38M | 69.38M | 69.38M | 69.38M | 69.93M | 69.93M | 69.93M | 69.93M | 80.58M | 80.58M | 80.58M | |||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 40.53M | 69.11M | 69.67M | 70.38M | 88.01M | ||||||||||||||||||
| EBITDA | 3.63M | 3.94M | 8.78M | 8.01M | 7.36M | 7.99M | 8.64M | 8.17M | 8.93M | 9.94M | 8.42M | 9.05M | 8.29M | 10.27M | 9.31M | 9.65M | 10.73M | 12.60M | 13.31M | 13.78M | |||
| Tax Rate | -0.10% | -0.37% | 0.01% | 0.30% | 0.34% | 0.09% | 0.26% | 0.30% | -0.79% | 0.11% | 0.01% | 0.04% | 0.02% | 1.15% | 0.65% | -0.07% | -0.29% | -0.05% | 0.50% |